Home / Netherlands / Imcd N.V.
Imcd N.V.
Short position disclosed on September 22, 2026.
4.75% of the capital sold short
6 disclosing funds
349 disclosures on record
NL0010801007 ISIN code
Evolution of the disclosed total
0%5%10%15%
Oct 2025Jan 2026Apr 2026Jul 2026
December 6, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Arrowstreet Capital, Limited Partnership | 1.19% | +0.50 pt | August 6, 2026 | |
| JPMorgan Asset Management (UK) Ltd. | 0.89% | new | August 11, 2026 | |
| Capital Fund Management S.A. | 0.80% | new | August 27, 2026 | |
| PDT Partners, LLC | 0.79% | new | July 24, 2026 | |
| Caisse de dépôt et placement du Québec | 0.58% | new | September 22, 2026 | |
| AQR Capital Management, LLC | 0.50% | -0.10 pt | August 31, 2026 |
In the United States IMDZF (OTC): 326,297 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Imcd N.V. Titelia
Get the moves on Imcd N.V. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 349 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.59% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Pharming Group N.V. 7.39% of the capital sold short
- Fugro N.V. 3.69% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- NSI N.V. 2.59% of the capital sold short
- PostNL N.V. 2.04% of the capital sold short
- Alfen N.V. 1.98% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
- Avantium N.V. 1.39% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Imcd N.V., source AFM, data as at September 22, 2026, https://www.quivad.com/action/imcd-n-v